Latest filing published 03 Oct 2006 for Synovics Pharmaceuticals, €173k.
Insider track record
No signal scores available.
Nirmal Mulye: trading record in brief
All filings by Nirmal Mulye on record concern Synovics Pharmaceuticals. Over a trading history stretching from 4 January 2006 to 31 March 2006, the count stands at 7 filings.
No open-market purchase appears, only 1 sale worth €173k.
Most recently, on 3 October 2006, the filings show an open-market sale worth €173k in Synovics Pharmaceuticals. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Nirmal Mulye
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 550,000 shares@ US$0.38Common Stock, par value $0.001SEC:0001144204-06-040673:0
- 50,000 shares@ US$0.50Common Stock, par value $0.001SEC:0001144204-06-040673:1
- 10,000 shares@ US$0.50Common Stock, par value $0.001SEC:0001144204-06-040673:2
- 5,000 shares@ US$0.50Common Stock, par value $0.001SEC:0001144204-06-040673:5
- 4,000 shares@ US$0.50Common Stock, par value $0.001SEC:0001144204-06-040673:6
5 of 5 declarations